ARAY — Accuray Incorporated Share News
0.000.00%
Last trade - 00:00- $20.76m
- $128.01m
- $401.95m
Accuray Inc expected to post a loss of 1 cent a share - Earnings Preview
Brief: Accuray Inc Says Reaffirming Guidance For Fiscal Year 2024
Brief: Accuray Incorporated Q2 revenue USD 107.238 million
Accuray Inc reports results for the quarter ended in December - Earnings Summary
Accuray Inc expected to post a loss of 5 cents a share - Earnings Preview
Brief: C-Rad Announces Order From Accuray
Brief: Accuray Initiates Sales Of The Vitalhold™ Solution In Japan, Supporting Surface-Guided Radiation Therapy On The Radixact® System
Accuray Inc expected to post a loss of 5 cents a share - Earnings Preview
Accuray Inc expected to post a loss of 5 cents a share - Earnings Preview
Brief: Accuray Says Co Cutting About 5.9% Global Workforce
Brief: Accuray Receives FDA Clearance For Vitalhold On The Radixact System Breast Cancer Treatment Option Will Also Be Available In The EU Market
Accuray Inc reports results for the quarter ended in June - Earnings Summary
Accuray Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: Accuray Incorporated Announces Its Addition To The Russell 2000® Index
Brief: Accuray Reports Fiscal 2023 Third Quarter Financial Results
Accuray Inc reports results for the quarter ended in March - Earnings Summary
Accuray Inc expected to post a loss of 1 cent a share - Earnings Preview
Brief: Accuray Inc Considers Exposure To Any Liquidity Concern At SVB Immaterial
Brief: Accuray - Qtrly Net Revenue Of $114.8 Million Decreased 1.3%